Cavelier Clara, Lorenzi Iris, Rohrer Lucia, von Eckardstein Arnold
Institute of Clinical Chemistry, University Hospital Zurich, University Zurich, Rämistrasse 100, CH 8091 Zurich, Switzerland.
Biochim Biophys Acta. 2006 Jul;1761(7):655-66. doi: 10.1016/j.bbalip.2006.04.012. Epub 2006 May 4.
Plasma levels of high-density lipoproteins (HDL) and apolipoprotein A-I (apoA-I) are inversely correlated with the risk of cardiovascular disease. One major atheroprotective mechanism of HDL and apoA-I is their role in reverse cholesterol transport, i.e., the transport of excess cholesterol from foam cells to the liver for secretion. The ATP-binding cassette transporters ABCA1 and ABCG1 play a pivotal role in this process by effluxing lipids from foam cells to apoA-I and HDL, respectively. In the liver, ABCA1 activity is one rate-limiting step in the formation of HDL. In macrophages, ABCA1 and ABCG1 prevent the excessive accumulation of lipids and thereby protect the arteries from developing atherosclerotic lesions. However, the mechanisms by which ABCA1 and ABCG1 mediate lipid removal are still unclear. Particularly, three questions remain controversial and are discussed in this review: (1) Do apoA-I and HDL directly interact with ABCA1 and ABCG1, respectively? (2) Does cholesterol efflux involve retroendocytosis of apoA-I or HDL? (3) Which lipids are directly transported by ABCA1 and ABCG1?
血浆中高密度脂蛋白(HDL)和载脂蛋白A-I(apoA-I)的水平与心血管疾病风险呈负相关。HDL和apoA-I的一种主要抗动脉粥样硬化机制是它们在逆向胆固醇转运中的作用,即把多余的胆固醇从泡沫细胞转运至肝脏以便分泌。ATP结合盒转运体ABCA1和ABCG1在此过程中发挥关键作用,它们分别将脂质从泡沫细胞排出至apoA-I和HDL。在肝脏中,ABCA1活性是HDL形成过程中的一个限速步骤。在巨噬细胞中,ABCA1和ABCG1可防止脂质过度蓄积,从而保护动脉不发生动脉粥样硬化病变。然而,ABCA1和ABCG1介导脂质清除的机制仍不清楚。特别是,有三个问题仍存在争议,本综述将对此进行讨论:(1)apoA-I和HDL是否分别直接与ABCA1和ABCG1相互作用?(2)胆固醇流出是否涉及apoA-I或HDL的逆向内吞作用?(3)ABCA1和ABCG1直接转运哪些脂质?